Sandbox:Sahar: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 111: Line 111:


clinical probability.
clinical probability.
| style="padding: 5px 5px; background: #FFFFE0;" align="center" |'''IIa'''
| style="padding: 5px 5px; background: #FFFACD;" align="center" |'''IIa'''
| style="padding: 5px 5px; background: #FFFFE0;" align="center" |'''B'''
| style="padding: 5px 5px; background: #FFFFE0;" align="center" |'''B'''
|
|
|-
|-
! style="padding: 5px 5px; background: #F5F5F5; "  align="left" |In case of low clinical
! style="padding: 5px 5px; "  align="left" |In case of low clinical


probability of AAS, negative D-dimer
probability of AAS, negative D-dimer
Line 124: Line 124:


diagnosis.
diagnosis.
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''IIa'''
| style="padding: 5px 5px; background: #FFFACD;" align="center" |'''IIa'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''C'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''C'''
|
|
Line 137: Line 137:


tests should be considered.
tests should be considered.
| style="padding: 5px 5px; background: #FFFFE0;" align="center" |'''IIa'''
| style="padding: 5px 5px; background: #FFFACD;" align="center" |'''IIa'''
| style="padding: 5px 5px; background: #FFFFE0;" align="center" |'''B'''
| style="padding: 5px 5px; background: #FFFFE0;" align="center" |'''B'''
|
|
|-
|-
! style="padding: 5px 5px; background: #F5F5F5; "  align="left" |In patients with high probability
! style="padding: 5px 5px;"  align="left" |In patients with high probability


(risk score 2 or 3) of AD,
(risk score 2 or 3) of AD,
Line 154: Line 154:
! colspan="4" align="left" |Imaging
! colspan="4" align="left" |Imaging
|-
|-
! style="padding: 5px 5px; background: #F5F5F5; "  align="left" |TTE is recommended as an
! style="padding: 5px 5px; background: #FFFFE0; "  align="left" |TTE is recommended as an


initial imaging investigation.
initial imaging investigation.
Line 161: Line 161:
!
!
|-
|-
! style="padding: 5px 5px; background: #F5F5F5; "  align="left" |In unstabled patients with a
! style="padding: 5px 5px; "  align="left" |In unstabled patients with a


suspicion of AAS, the following
suspicion of AAS, the following
Line 184: Line 184:
!
!
|-
|-
! style="padding: 5px 5px; background: #F5F5F5; "  align="left" |In stable patients with a
! style="padding: 5px 5px; background: #FFFFE0; "  align="left" |In stable patients with a


suspicion of AAS, the
suspicion of AAS, the
Line 210: Line 210:
|-
|-
!TOE
!TOE
!IIa
| style="padding: 5px 5px; background: #FFFACD;" align="center" |'''IIa'''
!C
!C
!
!
|-
|-
! style="padding: 5px 5px; background: #F5F5F5; "  align="left" |In case of initially negative
! style="padding: 5px 5px; background: #FFFFE0; "  align="left" |In case of initially negative


imaging with the persistence of
imaging with the persistence of
Line 227: Line 227:
!
!
|-
|-
! style="padding: 5px 5px; background: #F5F5F5; "  align="left" |Chest X-ray maybe
! style="padding: 5px 5px;"  align="left" |Chest X-ray maybe


considered in cases of low
considered in cases of low


clinical probability of AAS.
clinical probability of AAS.
!IIb
| style="padding: 5px 5px; background: #FFFACD;" align="center" |'''IIb'''
!C
!C
!
!
|-
|-
! style="padding: 5px 5px; background: #F5F5F5; "  align="left" |In case of uncomplicated
! style="padding: 5px 5px; background: #FFFFE0;"  align="left" |In case of uncomplicated


Type B AD treated medically,
Type B AD treated medically,

Revision as of 03:52, 25 December 2019

Recomendacations Class Level References
History and clinical assessment
In all patients with suspected

AAS, pre-test probability

assessment is recommended,

according to the patient’s

condition, symptoms, and

clinical features.

I B
Laboratory testing
In case of suspicion of AAS,

the interpretation of

biomarkers should always be

considered along with the pretest

clinical probability.

IIa B
In case of low clinical

probability of AAS, negative D-dimer

levels should be

considered as ruling out the

diagnosis.

IIa C
In case of intermediate clinical

probability of AAS with a

positive (point-of-care) D-dimer

test, further imaging

tests should be considered.

IIa B
In patients with high probability

(risk score 2 or 3) of AD,

testing of D-dimers is not

recommended.

III C
Imaging
TTE is recommended as an

initial imaging investigation.

I C
In unstabled patients with a

suspicion of AAS, the following

imaging modalities are

recommended according to

local availability and expertise:

TOE I C
CT I C
In stable patients with a

suspicion of AAS, the

following imaging modalities

are recommended (or should

be considered) according to

local availability and expertise:

CT I C
MRI I C
TOE IIa C
In case of initially negative

imaging with the persistence of

suspicion of AAS, repetitive

imaging (CT or MRI) is

recommended.

I C
Chest X-ray maybe

considered in cases of low

clinical probability of AAS.

IIb C
In case of uncomplicated

Type B AD treated medically,

repeated imaging (CT or

MRI)e during the first days is

recommended.

I C